Pharmacy Benefit Dimensions focuses on pharmacy benefit management services.

Pharmacy Benefit Dimensions

Pharmacy Benefit Dimensions | 854 followers on LinkedIn. URAC-accredited, our value-based pharmacy formulary helps deliver the right drug, to the right member, at the right time | Pharmacy Benefit Dimensions® experience managing pharmacy and medical benefits sets us apart from other pharmacy managers. This gives us a more powerful approach to achieve better quality pharmacy benefits at the lowest possible costs for our customers. It’s not simply about buying drugs for the lowest cost – it’s about helping ensure that our members receive the right prescription drug, at the right time.

Supervisor Pharmacy Prior Authorization and Benefit Administration at Pharmacy Benefit Dimensions

Stefan Brand

PMO and Transformation Leader - expertise in Operations, Business Process, and Continuous Improvement Methodologies

Andrew Lipp

Quality Assurance Auditor at Pharmacy Benefit Dimensions

Brian Fabian

Vice President of Business Development

Brian Przybysz

Join Dr. Aleem J. Merani, PharmD, MBA and Reliance Rx Specialty Pharmacy , Dr. Thomas Steele as they demonstrate through case studies and shared industry insights how aligning with the right partner can help combat the rising cost of specialty medication. Who should join: - Healthcare Brokers - TPAs - Plan Sponsors - HR Professionals #PBM #Specialtydrugs #Healthcare #Pharmacy #Pharmacybenefits #HR

PBD’s Dimensions Member Update🤝 Our latest edition is out, filled with insights to keep you updated on all thing's pharmacy benefits. This issue features a special seasonal trend piece, with wellness tips to help members balance holiday festivities with self-care. Read the newest Dimensions Member Update today: https://bit.ly/3Ce9rHW Check out the latest in member support, clinical insights, and practical holiday tips!

5 Stars, 4 Years in a Row 🌟🌟🌟🌟🌟 Pharmacy Benefit Dimensions is thrilled to have earned a 5-Star Rating from CMS for the fourth consecutive year—one of only two PBMs nationwide to achieve this quality status! With an average PDP Star Rating of just 3.06 in 2025, PBDRx stands out as a top choice for Medicare Employer Group Waiver Plan ( #EGWP ) Prescription Drug Plan ( #PDP ) excellence. Why Star Ratings Matter: Choosing a highly rated PDP means ensuring top-tier support in customer service, competitive drug pricing, patient safety, and overall client satisfaction. This achievement reinforces our commitment to delivering trusted solutions that prioritize value and outstanding service. Learn more: https://bit.ly/3YRARwi #CMS #MedicareExcellence #PharmacyBenefitManagement #ClientSatisfaction #HealthcareQuality

📢 Pulse Newsletter: Your Go-To Source for PBM and Drug Safety Updates Catch up on the latest in clinical pharmacy, drug safety, and pharmaceutical advancements—all in just a few minutes. 🔬 Clinical Pharmacy Update FDA approves Hympavzi™ for hemophilia A and B ⚠️ Drug Safety Bionpharma recalls one batch of Atovaquone Oral 💉 Pharmaceutical News The FDA authorizes Healgen Rapid Check COVID-19/Flu A&B Antigen Test 🆕 FDA Approvals Itovebi™ joins the breast cancer treatment landscape 📈 New Generics Roxybond® (oxycodone) now available as a generic, supporting severe pain management. 🔗 Read the full newsletter: https://bit.ly/3As2C51 #PharmacyNews #DrugSafety #FDAApprovals #PBMIndustry #HealthcareUpdates #PulseNewsletter

Pulse Newsletter: Latest PBM and Drug News You Can’t Miss 📢 Stay informed with cutting-edge updates in clinical pharmacy, drug safety, and pharmaceutical breakthroughs—all in under 5 minutes. 🔬 Clinical Pharmacy Update FDA approves new drug for schizophrenia ⚠️ Drug Safety Gilead Sciences, Inc. issued a voluntary recall 💉 Pharmaceutical News National GLP-1 supply begins to stabilize 🆕 FDA Approvals New Drug: Miplyffa™ for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) 📈 New Generics Tazorac® (tazarotene) cream: For plaque psoriasis. 🔗 Read the full newsletter: https://bit.ly/4eJW2FL

We wear pink in honor of the courageous breast cancer survivors and in remembrance of those we've lost. At Pharmacy Benefit Dimensions , we believe in supporting the fighters, celebrating the survivors, and raising awareness for the continued fight against breast cancer. Together, let's foster hope, strength, and unity in this battle. 💗 #BreastCancerAwareness #WearPink #PBDCares

Pulse Newsletter: Latest PBM and Drug News You Can’t Miss 📢 Stay informed with cutting-edge updates in clinical pharmacy, drug safety, and pharmaceutical breakthroughs—all in under 5 minutes. 🔬 Clinical Pharmacy Update FDA approves new drug for moderate-to-severe eczema ⚠️ Drug Safety Warning added by FDA about rare occurrence of serious liver injury 💉 Pharmaceutical News First over-the-counter hearing aid software authorized by FDA 🆕 FDA Approvals New Dosage Form: Ocrevus Zunovo™ for the treatment of primary progressive and relapsing forms of multiple sclerosis in adult patients 📈 New Generics Sprycel® (dasatinib): For certain types of cancers Oxtellar XR® (oxcarbazepine): Treatment for partial-onset seizures in patients 6 years and older. 🔗 Read the full newsletter: https://bit.ly/3ZIx6tQ #PharmacyNews #DrugSafety #FDAApprovals #HealthcareUpdates #PBMIndustry #PulseNewsletter

When a major organization faced a sudden disruption in ADHD medication access, they needed immediate support. PBD stepped in with proactive cost solutions, ensuring uninterrupted therapy and financial relief for their members. Learn how we turned a challenge into care-driven results and read the full story below! #PBMsolutions #Healthcareinnovation #Clientcare

Pulse Newsletter: Latest PBM and Drug News You Can’t Miss 📢 Stay informed with cutting-edge updates in clinical pharmacy, drug safety, and pharmaceutical breakthroughs—all in under 5 minutes. 🔬 Clinical Pharmacy Update FDA approves drug for prurigo nodularis, offering relief from severe itching and inflammation for patients with this chronic skin disease ⚠️ Drug Safety B. Braun Medical recalls two lots of 0.9% Sodium Chloride IV bags 💉 Pharmaceutical News FDA grants EUA for three updated COVID-19 vaccines targeting the Omicron variant JN.1 🆕 FDA Approvals Two new drugs hit the market: Lazcluze™ for non-small cell lung cancer Pavblu™, a biosimilar to EYLEA®, for treating vascular retinal diseases 📈 New Generics Lucemyra™ is now available as a generic to manage opioid withdrawal symptoms 🔗 Read the full newsletter: https://bit.ly/3TwKldk #PharmacyNews #DrugSafety #FDAApprovals #HealthcareUpdates #PBMIndustry #PulseNewsletter

🚨 Pulse Newsletter: Essential Updates in PBM & Drug Safety 🚨 Delivered right to your feed—quick, concise, and impactful. 🔍 Clinical Pharmacy Update FDA approves the first needle-free nasal spray for emergency treatment of anaphylaxis. ⚠️ Drug Safety Baxter recalls a lot of Heparin Sodium Injection—your safety, our priority. 💊 Pharmaceutical News FDA greenlights auto-Injector to combat opioid overdoses. 🆕 New Drugs Yorvipath® for hypoparathyroidism Livdelzi® for rare blood disorders like PNH and aHUS. Stay informed and ahead of the curve! 🔗 Read the full newsletter: https://bit.ly/47aJy7g #PharmacyNews #DrugSafety #FDAApprovals #HealthcareUpdates #PBMIndustry #PulseNewsletter

PBDR

COM:PBDRX

Pharmacy Benefit Dimensions